Synthesis and Biological Evaluation of Novel Imidazolinone Derivatives

 

B. C. Revanasiddappa*, M. Vijay Kumar, Prashanth Nayak,  Ajmal Roshan Ali, Jasmine Kalsi

Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences of Nitte University, Paneer, Deralakatte, Mangalore-575 018 Karnataka, India

*Corresponding Author E-mail: evergreen_revan@rediffmail.com

 

ABSTRACT:

A new series of Oxazolones (2a-j) were prepared by reacting substituted aromatic aldehydes with N-acetylglycine in presence of anhydrous sodium acetate and acetic anhydride as the solvent medium. The respective Oxazolones (2a-j) were then treated with 4-Amino-1,2,4-triazole (1) in glacial acetic acid medium to yield the title compounds Imidazolinones (3a-j). All the newly synthesized compounds were evaluated for their In –Vitro antibacterial and antifungal activities. The new compounds were assigned on the basis of 1H-NMR, IR, Mass spectral data and elemental analysis.

 

KEYWORDS:  Oxazolones, Imidazolinones, N-acetylglycine, Antibacterial, Antifungal

 

 

 

 


INTRODUCTION:

In heterocyclic chemistry, the five membered compounds are known to be an important class of compounds because of their wide variety of pharmacological and biological activities. Nitrogen containing heterocycles play an important role, not only for life science industry but also in many other industrial fields related to synthetic chemistry. In the present work, we have planned to synthesize, Imidazolinones, a five membered heterocyclic compound, and a derivative derived from Imidazole. It belongs to five membered Nitrogen heterocycles.

 

Imidazole is a planer five-membered heterocyclic ring system with three carbon and two nitrogen atoms in 1 and 3 positions. Imidazolones are keto dihydro imidazoles. Imidazolone that is known as oxoimidazoline is a five- membered heterocyclic ring system having nitrogen atoms in 1 and 3 positions and carbonyl group in 5 positions.

 

During the past decade a large number of Imidazole/Imidazolines have been found to be associated with various therapeutic activities. Naphazoline hydrochloride, Xylometazoline hydrochloride etc. are various Imidazolinone derivatives which have been used as adrenergic stimulants and Tolazoline, Phenotolamine are used as adrenergic blocking agents, Cimetidine as antiulcer, Dacarbazine as anticancer agents. Recently some new Imidazolinone derivatives have been reported as antimicrobial1, MAO inhibitors2, CNS depressants3, analgesic4, antiparkinsonian5, antihelmintics6,  anticonvusalnt7  and  enzyme inhibitory agents8.

 

Prompted by these observations and in continuation of our research on the synthesis of biologically active nitrogen heterocycles9-11, we herein report the synthesis of antibacterial and antifungal activity of novel series of Imidazolinone derivatives.

 

MATERIALS  AND METHODS:

The homogeneity of the compounds was checked by TLC using silica gel plates (Merck) using ethyl acetate: methanol as mobile phase. Melting points were determined by open capillary method and are uncorrected. The IR spectra are recorded by using Alpha Bruker IR Spectrometer using a thin film on KBr pellet technique and frequencies are expressed in cm-1. The 1H-NMR spectra were recorded on Bruker Avance II 400 MHz NMR Spectrometer. All the spectra were obtained in CDCl3 and DMSO. Chemical shift values are reported as values in ppm relative to TMS (δ=0) as internal standard. Mass spectra were recorded on ESI. Elemental analysis was carried out on Vario-El elemental-III model analyzer.

 

All the chemicals such as aromatic aldehydes, N-acetyl glycine, 4-amino-1,2,4-triazole were procured from Himedia labs, Mumbai and were used without further purification. The key intermediates Oxazolones (2a-j) were prepared as per the reported procedure13.

General procedure for the synthesis of substituted Imidazolinones (3a-j)

A solution of Oxazolones (2a-j) (0.01 mol) and 4-Amino-1,2,4-triazole (1) (0.01 mol) in glacial acetic acid (25 ml) was refluxed for about 21-26 hr. Excess of solvent was removed under reduced pressure and the reaction mixture was poured  into ice cold water. The precipitated compound is filtered, washed with water and recrystallized from ethanol. The physical data of compounds (3a-j) is given in table-1.

 

 


Table-1: Physical data of Imidazolinones (3a-j)

Comp.

 

R-CHO

M.P

(0C)

Elemental analysis Calculated (Found)

Yield

(%)

C (%)

H (%)

N (%)

3a

C6H5

90-92

61.65

(61.68)

4.38

(4.42)

27.65

(27.68)

62

3b

4-F

135-137

57.56

(57.53)

3.72

(3.76)

25.82

(25.86)

63

3c

4-NO2

80-82

52.35

(52.38)

3.38

(3.35)

28.18

(28.22)

65

3d

2-Cl

120-122

54.27

(54.24)

3.50

(3.54)

24.34

(24.37)

67

3e

4-Cl

116-118

54.27

(54.24)

3.50

(3.54)

24.34

(24.37)

65

3f

4-OH

129-131

57.99

(57.96)

4.12

(4.15)

26.01

(26.05)

69

3g

2-OH

166-168

57.99

(57.96)

4.12

(4.15)

26.01

(26.05)

66

3h

4-OCH3

101-103

59.36

(59.39)

4.63

(4.66)

24.72

(24.76)

66

3i

3,4-(OCH3)2

156-158

57.50

(57.54)

4.83

(4.86)

22.35

(22.38)

67

3j

3,4,5-(OCH3)3

176-178

55.97

(55.94)

4.99

(5.03)

20.40

(20.44)

64

 

 

 


(Z)-4-benzylidene-2-methyl-1-(4H-1,2,4-triazol-4-yl)-1H-imidazol-5(4H)-one 3a

Yield: 62%,

M.P.:90-92OC, 

IR (Vmax, KBr): 1449(C=C), 1643(C=N), 1711(C=O), 3060(C-H),

1H-NMR (CDCl3, 400 MHz, δ): 2.19 (s, CH3, 3H), 7.10-7.73 (m, Ar-H, 2H of 1,2,4-triazole, 7H),12.06(s, C=CH, 1H), 

MS(m/z): 253(M+)

 

(Z)-4-(4-fluorobenzylidene)-2-methyl-1-(4H-1,2,4-triazol-4-yl)-1H-imidazol-5(4H)-one 3b

Yield: 63%,

M.P.: 135-137OC,

IR(Vmax,KBr):837(C-F), 1509(C=C), 1599(C=N), 1721(C=O),  3073(C-H),

1H-NMR (CDCl3, 400 MHz, δ): 2.18 (s, CH3 ,3H) ,7.17-7.75 (m, Ar-H, 2H of 1,2,4-triazole, 6H),12.10(s, C=CH, 1H), 

MS(m/z): 271(M+)

 

(Z)-2-methyl-4-(4-nitrobenzylidene)-1-(4H-1,2,4-triazol-4-yl)-1H-imidazol-5(4H)-one 3c

Yield: 65%,

M.P.:80-82OC, IR(Vmax,KBr):1513,1345(NO2),1600(C=N),1710(C=O), 2932(C-H),

1H-NMR (CDCl3, 400 MHz, δ):2.18 (s, CH3, 3H), 7.17-7.74 (m, Ar-H, 2H of 1,2,4-triazole, 6H) ,12.07(s, C=CH, 1H).

 

 

 

(Z)-4-(2-chlorobenzylidene)-2-methyl-1-(4H-1,2,4-triazol-4-yl)-1H-imidazol-5(4H)-one 3d

Yield: 67%,

M.P.:120-1222OC,

IR(Vmax,KBr): 753(C-Cl), 1519(C=C), 1641(C=O), 3062(C-H);

1H-NMR (CDCl3, 400 MHz, δ):2.21 (s, CH3, 3H), 7.11-7.83 (m, Ar-H, C=CH, 2H of 1,2,4-triazole, 7H).

 

Antibacterial activity

The compounds (3a-j) were screened for their antibacterial potential against four pathogenic organisms viz. S.aureus, P.aeruginosa, E.coli and B.subtilis by Cup-Plate method12 at 100 µgm/ml. Ciprofloxacin was used as standard. All the tested compounds showed weak to moderate activity against all the four pathogenic micro-organisms. None of the compounds showed significant activity when compared to the standard drug Ciprofloxacin. The antimicrobial data of the compounds (3a-j) is given in table-2.

 

Antifungal activity

The compounds (3a-j) were screened for their antifungal activity against A.flavus and A.fumigatus. The technique used was Cup-Plate method12 at 100 µgm/ml.. Flucanazole was used as standard. The tested compounds showed moderate activity against A.fumigatus and compounds with electron withdrawing groups like NO2, Cl showed good activity upon comparison with standard Flucanazole. All the tested compounds showed very weak activity against A.flavus. The antifungal data of the compounds (3a-j) is given in table-2.

 

 


 

Table 2: Antimicrobial activity of Compounds (3a-j)

Comp.

Diameter of zone of inhibition (mm)

S.aureus

B.subtilis

E.coli

P.aeruginosa

A.flavus

A.fumigatus

3a

08

12

13

08

12

08

3b

07

12

12

07

08

08

3c

08

08

08

08

12

21

3d

13

12

12

13

07

21

3e

12

08

08

12

13

21

3f

11

11

11

09

12

13

3g

10

10

10

10

10

12

3h

11

11

10

11

10

09

3i

12

10

11

12

11

11

3j

10

12

12

10

11

10

Ciprofloxacin

24

24

24

23

-

-

Fluconazole

-

-

-

-

24

24

 


 

 

 

 

 

 

 

 

 

 

 

 

RESULTS AND DISCUSSION:

Oxazolones  (2a-j)were prepared based on the special type of Perkin condensation reaction, in which the reaction between substituted aromatic aldehydes with N-acetylglycine proceeds first, followed by ring closer reaction. It is observed that aldehyde condenses under the influence of  a base with active methylene group in the azalactone, which is formed by the dehydration of N-acetylglycine, when the later reacts with Ac2O in presence of sodium acetate.

 

The title compounds substituted Imidazolinones (3a-j) were prepared by reacting Oxazolones (2a-j) and 4-Amino-1,2,4-triazole (1) in glacial acetic acid medium. The target compounds were prepared by the method outlined in Scheme-01. All the new compounds were characterized by spectral data and also evaluated for biological evaluation. The structures of the novel compounds were elucidated by spectral methods.

In compound 3a, the CH stretching was observed at 3060. The Imidazolinone C=O and C=N stretching was observed at 1710 and 1643 respectively. The 1H-NMR of this compound 3a showed the methyl protons resonated as singlet at 2.19 integrating for three protons. The signals due to aromatic protons resonated as multiplets in the region 7.10-7.30 integrating for seven protons of Imidazolinone and triazole. The C=CH proton came into resonance as a singlet at 12.06 Further evidence for the proposed structure was obtained by recording mass spectra of the synthesized compounds. The mass spectrum of the compound 3a showed the M+ peak at 253 which is consistence with its molecular formula.

 

CONCLUSION:

A novel series of imidazolinones were synthesized and evaluated for antibacterial and antifungal activities. All the new compounds were assigned on the basis of spectral data. Some of the tested compounds showed weak antibacterial activity and good antifungal activity.

 

ACKNOWLEDGEMENTS:

Authors are thankful to the authorities of NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore for providing all the necessary facilities. The authors are thankful to SAIF, Punjab University, Chandigarh and Oxygen Health Care Research Pvt. Ltd, Ahmadabad for providing spectral data.

 

REFERENCES:

1.     Hirpara KV, Patel SP, Parikh KA, Bhimani AS,  Parekh HH. Preparation, characterization and antimicrobial activities of some novel nitriles and imidazolines.  J. Sci. Islam. Rep Iran. 15; 2004: 135-39.

2.     Harfenist M. Soroko EF, Mckenzie GM. 2-(Alkoxyaryl)-2-imidazoline monoamine oxidase inhibitors with antidepressant activity. J. Med. Chem. 21;1978: 405-09

3.     Mukerji D, Nautiyal SR, Prasad CR. Synthesis of some new 1-(2’-methoxy-4’-nitrophenyl)-2-methyl-4-substituted benzylidine-5-imidazolones as CNS depression compounds.  Ind. Drugs. 18; 1981: 125-31.

4.     Khan MS, Gupta M. Synthesis and evaluation of anti-inflammatory and analgesic activity of some new 1,3-diphenyl-2- aryl tetrahydro imidazoles. Ind. J. Chem. 42B; 2003: 2086–90.

5.     Naithani DK, Srivastava VK, Barthwal JP, Saxena AK, Gupta TK, Shanker K. Synthesis and antiparkinsonian activity of newer imidazolones.  Ind. J. Chem. 28B; 1989:  990-96.

6.     Imtiaz  HM,  Vinaykumar. Synthesis of 2-(2-benzothiazolyl/ benzoxazolylthio)-N- [4,5-dihydro-4-((substituted phenyl) methylene)-5-oxo-2-phenyl/methyl-1H-imidazole-1-l]acetamides as possible anthelmintics. Ind. J. Chem. 31B; 1992:  285-88.

7.     Upadhyay PS, Joshi HD, Baxi AJ, Parikh AR.. Synthesis and pharmacological evaluation of some new imidazolinones as anticonvusants.  Ind. J. Het. Chem. 1;1991: 71-74.

8.     Meenakshi S, Reena K, Renu S, Dixit KS, Nath C, Barthwal JP.Synthesis, anticonvulsant and enzyme inhibitory activities of some indolyl-1,3,4-thiadiazoles. Ind. J. Chem. 29B; 1990: 85-90

9.     Revanasiddappa BC, Subrahmanyam EVS, Lakshmi TN. Synthesis and biological evaluation of Pyrazolines. Ind. J. Pharm. Edu. Res. 45;2011: 164-67.

10.   Revanasiddappa BC, Kalsi J. Jisha,MS. Jose N,  Varghese SS. Synthesis and biological evaluation of some novel imidazolinone derivatives. Ind. J. Het. Chem. 22; 2013: 225-28.

11.   Revanasiddappa, B.C,; Kalsi, J.; Jisha, M.S.; Varghese, S.S,; Jose, N. Synthesis and biological evaluation of novel imidazolinone derivatives carrying Benzimidazole,  Ind. J. Het. Chem. 2015, 25, 01-04.

12.   Cruichshank R, Duguid JP, Marmoin BP, Swan HA. The practice of medical microbiology. Churchill Livingstone, London. 1975; Vol 2,  12th ed: pp-190-195

13.   Furniss BS, Hannaford AJ, Smith, PWG, Tatchell AR.. Vogel’s text book of practical organic chemistry. Pearson Education, London. 2004; 5th ed: p p-1156-1160.

 

 

 

 

Received on 05.04.2017          Modified on 28.04.2017

Accepted on 12.05.2017        © RJPT All right reserved

Research J. Pharm. and Tech. 2017; 10(6): 1726-1729.

DOI: 10.5958/0974-360X.2017.00304.3